Adding OCALIVA

Leslie, 58 Joined #TeamOCALIVA in 2017

OCALIVA enhances the treatment of PBC

If you have primary biliary cholangitis (PBC), you may already be taking ursodiol (also called ursodeoxycholic acid or UDCA) to slow or stop liver damage. But some people with PBC don’t respond adequately to treatment with UDCA. Is your ALP (alkaline phosphatase) level as low as it could be? Ask your doctor, because a higher-than-normal ALP level could mean an increased risk of liver damage.

OCALIVA® (obeticholic acid) is an add-on* treatment that can work to reduce ALP levels even more than ursodiol alone.

Most people who added OCALIVA to ursodiol saw their ALP level lowered by more than 15%.†‡

  • Taking OCALIVA with ursodiol

    • Adding OCALIVA to ursodiol can help lower ALP
    • After 1 year of treating PBC with ursodiol alone, a routine blood test can determine whether it’s working adequately. If not, another option may be able to help
  • Taking OCALIVA alone

    • Some people with PBC are unable to tolerate ursodiol and require a different treatment option
    • For people who are unable to tolerate ursodiol, OCALIVA can be taken alone
  • *OCALIVA is a prescription medicine used to treat PBC in combination with UDCA in adults who have not responded well enough to UDCA, or alone for adults who cannot tolerate UDCA.
  • In a study of OCALIVA, all participants with PBC were taking ursodiol for at least 12 months or were unable to tolerate ursodiol and did not receive it for at least 3 months.
  • In a clinical study testing the effectiveness of OCALIVA, patients showed a reduction in the level of the liver enzyme ALP. There is no clinical information currently available to show if patients treated with OCALIVA live longer or if their symptoms improve. There are ongoing studies to find out how OCALIVA works over a longer period of time.

Want to learn more about PBC and treating with OCALIVA?

Sign up to get PBC-related news and information, tools, tips, and other materials sent to you.

Watch and Learn

Learn how OCALIVA can help treat PBC and if it could be right for you.

What is OCALIVA?

Learn more about this PBC treatment option

Candidates for OCALIVA

Find out who it may be right for

“My trick to taking OCALIVA is just do it at the same time and the same place every day.”

Rosalía, a person living with PBC

Could you do more to treat your PBC?

Even if you’re already on treatment, there may be more you can do to manage PBC. Choose the discussion guide that best describes you, to help you have the right conversation with your doctor.

Indication and Important Safety Information

What is OCALIVA?

OCALIVA is a prescription medicine used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have not responded well enough to UDCA, or alone for adults who cannot tolerate UDCA. It is not known if taking OCALIVA will improve your chance of survival or improve your symptoms of PBC. It is not known if OCALIVA is safe and effective in children.

What is the most important information I should know about OCALIVA?

OCALIVA may cause serious side effects including:

Worsening of liver problems or liver failure, in some cases leading to liver transplant or death, has happened in people with primary biliary cholangitis (PBC) with liver cirrhosis when taking OCALIVA.

Before you start OCALIVA, and during your treatment with OCALIVA, your healthcare provider will do tests to check your liver. These tests will help your healthcare provider decide if it is safe for you to start taking OCALIVA and safe for you to continue taking OCALIVA.

Tell your healthcare provider right away if you have any of the following symptoms of worsening liver problems during treatment with OCALIVA:

  • Swelling of your stomach‑area from a build‑up of fluid; yellowing of your skin or the whites of your eyes; black, tarry, or bloody stools; coughing up or vomiting blood, or your vomit looks like “coffee grounds”; mental changes such as confusion, sleepier than usual or harder to wake up, slurred speech, mood swings, or changes in personality.

Tell your healthcare provider right away if you have any of the following symptoms during treatment with OCALIVA and they are severe or do not go away:

  • Stomach‑area pain; nausea, vomiting, or diarrhea; loss of appetite or weight loss; new or worsening fatigue; weakness; fever and chills; light‑headedness; less frequent urination

Who should not take OCALIVA?

Do not take OCALIVA if you:

  • have PBC with liver cirrhosis with symptoms such as fluid in the stomach‑area or confusion (decompensated liver cirrhosis) or with abnormalities in certain tests that check your liver.
  • have a complete blockage of the bile ducts in your liver or gallbladder.

What are the possible side effects of OCALIVA?

OCALIVA may cause serious side effects, including:

  • See “What is the most important information I should know about OCALIVA?”
  • Severe Itching (pruritus). Itching is a common side effect and can sometimes become severe (intense itching or itching over much of your body). Severe itching can cause discomfort, problems sleeping, and problems doing daily activities and usually needs to be treated. Tell your healthcare provider if you get severe itching or if your itching gets worse.
  • Lower HDL‑C (“good” cholesterol). OCALIVA can lower high levels of HDL‑C. Your healthcare provider will check your cholesterol levels during treatment with OCALIVA.

The most common side effects of OCALIVA include: tiredness; stomach pain and discomfort; rash; joint pain; mouth and throat pain; dizziness; constipation; swelling in your hands, ankles, or feet; fast or irregular heartbeat; fever; changes in how your thyroid gland works; dryness, irritation, redness, crusting or drainage of the skin (eczema).

These are not all the possible side effects of OCALIVA. Call your doctor for medical advice about side effects.

What should I tell my healthcare provider before taking OCALIVA?

Before taking OCALIVA, tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or plan to become pregnant. It is not known if OCALIVA will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if OCALIVA passes into your breastmilk. Talk with your healthcare provider about the best way to feed your baby if you take OCALIVA.

Tell your healthcare provider about all the medicines you take, including prescription and over‑the‑counter medicines, vitamins, and herbal supplements. OCALIVA can affect the way certain medicines work. Certain other medicines may affect the way OCALIVA works.

The risk information provided here is not complete. To learn more, please talk to your healthcare provider.

Please click here for Full Prescribing Information and Medication Guide for OCALIVA.

Available by prescription only.

To report negative side effects of OCALIVA, please contact Intercept Pharmaceuticals, Inc. at 1-844-782-ICPT or you may report to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.